Cargando…
A Study of the Management of Patients Taking Novel Oral Antiplatelet or Direct Oral Anticoagulant Medication Undergoing Dental Surgery in a Rural Setting
Purpose: Novel oral antiplatelet (NOAP) (prasugrel and ticagrelor) and direct oral anticoagulant drugs (DOAC) (dabigatran, rivaroxaban and apixaban) have emerged in the last decade. This study was undertaken to determine current approaches taken to the management of patients taking these agents in d...
Autor principal: | Johnston, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851194/ https://www.ncbi.nlm.nih.gov/pubmed/29567930 http://dx.doi.org/10.3390/dj3040102 |
Ejemplares similares
-
A surgeon's guide to anticoagulant and antiplatelet medications part one: warfarin and new direct oral anticoagulant medications
por: McBeth, Paul B, et al.
Publicado: (2016) -
Implications of direct oral anticoagulation and antiplatelet therapy in intensive care
por: Willcox, Abbey, et al.
Publicado: (2023) -
Outpatient cervical brachytherapy in the setting of ongoing antiplatelet therapy or oral anticoagulation
por: Valakh, Vladimir, et al.
Publicado: (2018) -
Dental management of patients taking novel oral anticoagulants (NOAs): Dabigatran
por: Curto, Adrian, et al.
Publicado: (2017) -
Patients Taking Direct Oral Anticoagulants (DOAC) Undergoing Oral Surgery: A Review of the Literature and a Proposal of a Peri-Operative Management Protocol
por: Lupi, Saturnino Marco, et al.
Publicado: (2020)